Date: 2025/02/21 - 21:31

What one man's 'escape' from Alzheimer's might tell us about the disease

A 75-year-old man with a genetic predisposition for Alzheimer’s has yet to show signs of the disease. Could this offer insights on new preventive and therapeutic avenues?

Date: 2025/02/14 - 22:00

New test may detect Alzheimer's years before tau clumps show up in scans

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the brain before it causes significant damage.

Date: 2025/02/03 - 17:00

Some bacteria in the mouth may play a role in memory loss and dementia

Date: 2025/01/31 - 21:00

Can cannabis affect memory? Largest study yet investigates

Heavy cannabis use may negatively impact a person’s working memory, according to the largest study on this subject to date.

Date: 2025/01/29 - 20:00

Taking longer to get to REM sleep could indicate Alzheimer's disease

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, a new study indicates.

Date: 2025/01/28 - 15:31

Calorie restriction plus common diabetes drug leads to higher remission rates

A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes remission compared to just calorie restriction alone, new research has found.

Date: 2025/01/23 - 22:31

Could intermittent fasting earlier in the day help reduce more abdominal fat?

Following an "early" time-restricted intermittent fasting pattern is more beneficial for improved blood sugar regulation, and reducing the amount of abdominal fat just under the skin, a new study has found.

Date: 2025/01/22 - 19:00

Can antibiotics, vaccines, and antivirals help lower dementia risk?

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a reduced risk of dementia, a new systematic review suggests.

Date: 2025/01/22 - 00:32

GLP-1 Drugs Benefit Brain and Heart Health, but May Cause Kidney, GI Issues

A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but risks of developing gastrointestinal, kidney, and pancreatic issues.

Date: 2025/01/21 - 20:31

GLP-1 drugs linked to lower dementia risk, higher risk of kidney, stomach issues

A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.